Influence of gender on loss to follow-up in a large HIV treatment programme in western kenya;Influence du sexe de la personne sur la perte du suivi dans un vaste programme de traitement du VIH dans l'ouest du Kenya

Bulletin of the World Health Organization

Volumn 88, Issue 9, 2010, Pages 681-688

  Ochieng Ooko, Vincent ^a   Ochieng, Daniel ^a   Sidle, John E ^b   Holdsworth, Margaret ^a   Wools Kaloustian, Kara ^b   Siika, Abrahamm ^b   Yiannoutsos, Constantin T ^d   Owiti, Michael ^c   Kimaiyo, Sylvester ^c   Braitstein, Paula ^b  

^a UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOI UNIVERSITY   (Kenya)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE INCIDENCE; DISEASE TREATMENT; GENDER DISPARITY; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENDER; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERPERSONAL COMMUNICATION; KENYA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PROBABILITY; RISK FACTOR; TRAVEL; URBAN AREA;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; KENYA; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

KENYA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77956922651     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.09.064329     Document Type: Article

References (24)

1. Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2008.
2. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector-progress report. Geneva: World Health Organization; 2009.
3. May M, Sterne JA, Sabin C, Costagliola D, Justice AC, Thiebaut R., et al.Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007;21:1185-1197. doi:10.1097/QAD.0b013e328133f285 PMID:17502729
4. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P., et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-824. doi:10.1016/S0140-6736(06)68337-2 PMID:16530575
5. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH., et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006;296:782-793. doi:10.1001/jama.296.7.782 PMID:16905784
6. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007;4:e298. doi:10.1371/journal.pmed.0040298 PMID:17941716
7. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C., et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 2008;17:47-55. doi:10.1089/jwh.2007.0353 PMID:18240981
8. Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006;20:41-48. doi:10.1097/01.aids.0000196177.65551.ea PMID:16327318
9. Nicastri E, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A., et al. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005;19:577-583. doi:10.1097/01.aids.0000163934.22273.06 PMID:15802976
10. Moore AL, Sabin CA, Johnson MA, Phillips AN. Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study. J Acquir Immune Defic Syndr 2002;29:197-202. PMID:11832692
11. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D., et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 2008;86:559-567. doi:10.2471/BLT.07.044248 PMID:18670668
12. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ., et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 2007;85:550-554. doi:10.2471/BLT.06.037739 PMID:17768504
13. Einterz RM, Kimaiyo S, Mengech H, Khwa-Otsyula B, Esamai F. Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med 2007;82:812-818. doi:10.1097/ACM.0b013e3180cc29f1 PMID:17762264
14. Tierney W, Rotich J, Hannan T, Siika A, Biondich P, Mamlin B, et al. The AMPATH medical record system: creating, implementing, and sustaining an electronic medical record system to support HIV/AIDS care in western Kenya. In: Kuhn KA, Warren JR, Leong TY, eds. Medinfo 2007: proceedings of the: 12th World Congress on Health (Medical) Informatics. Amsterdam: IOS Press; 2007.
15. Siika AM, Rotich JK, Simiyu CJ, Kigotho EM, Smith FE, Sidle JE., et al. An electronic medical record system for ambulatory care of HIV-infected patients in Kenya. Int J Med Inform 2005;74:345-355. doi:10.1016/j.ijmedinf.2005.03.002 PMID:15893257
16. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M., et al. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 2008;3:e1725. doi:10.1371/journal.pone.0001725 PMID:18320045
17. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF., et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008;47:101-107. doi:10.1097/QAI.0b013e31815b833a PMID:17971708
18. Chen SC, Yu JK, Harries AD, Bong CN, Kolola-Dzimadzi R, Tok TS., et al. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Trop Med Int Health 2008;13:513-519. PMID:18282238
19. Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr J,L., et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 2007;45:1492-1498. doi:10.1086/522991 PMID:17990233
20. Braitstein P, Siika A, Hogan J, Kosgei R, Sang E, Sidle J, et al. High-risk express care: a novel care model to reduce early mortality among high-risk HIV-infected patients initiating combination antiretroviral treatment. Presented at the: XVII International AIDS Conference, Mexico City, Mexico, 3-8 August 2008.
21. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410-414. doi:10.1016/S0140-6736(01)05551-9 PMID:11502341
22. McCoy D, Chopra M, Loewenson R, Aitken JM, Ngulube T, Muula A.,et al. Expanding access to antiretroviral therapy in sub-Saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. Am J Public Health 2005;95:18-22. doi:10.2105/AJPH.2004.040121 PMID:15623853
23. Wools-Kaloustian K, Kimaiyo S, Musick B, Sidle J, Siika A, Nyandiko W., et al. The impact of the President's Emergency Plan for AIDS Relief on expansion of HIV care services for adult patients in western Kenya. AIDS 2009;23:195-201. doi:10.1097/QAD.0b013e32831cc0e6 PMID:19098489
24. Mamlin J, Kimaiyo S, Lewis S, Tadayo H, Jerop FK, Gichunge C.,et al. Integrating nutrition support for food-insecure patients and their dependents into an HIV care and treatment program in western Kenya. Am J Public Health 2009;99:215-221. doi:10.2105/AJPH.2008.137174 PMID:19059851